USNA Stock Recent News

USANA Health Sciences, Inc. (NYSE:USNA ) Q4 2022 Earnings Conference Call February 8, 2023 11:00 AM ET Company Participants Andrew Masuda - Investor Relations Kevin Guest - Chairman and Chief Executive Officer Jim Brown - President Doug Hekking - Chief Financial Officer Brent Neidig - Chief Officer and Managing Director, China Conference Call Participants Linda Bolton-Weiser - D.A. Davidson Susan Anderson - Canaccord Genuity Ivan Feinseth - Tigress Financial Partners Operator Good day and welcome to today's USANA Health Sciences Fourth Quarter Earnings Conference Call.

Usana Health Sciences Inc. shares fell more than 4% in the extended session Thursday after the multi-level marketing company called for lower 2023 sales and profit than Wall Street expected, saying it is unsure whether an uptick in sales at the end of 2022 would last.

SALT LAKE CITY--( BUSINESS WIRE )--USANA Health Sciences, Inc. (NYSE:USNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti December Virtual Investor Conference, taking place on December 7-8, 2022.

USANA Health Sciences, Inc. (NYSE:USNA ) Q3 2022 Earnings Conference Call October 26, 2022 11:00 AM ET Company Participants Andrew Masuda – Investor Relations Kevin Guest – Chief Executive Officer and Chairman of the Board Doug Hekking – Chief Financial Officer Conference Call Participants Linda Bolton-Weiser – D.A. Davidson Operator Hello, and welcome to USANA Health Sciences Third Quarter Earnings Call.

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter results will be released after the close of market on Tuesday, October 25, 2022. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and instituti

USANA Health (USNA) delivered earnings and revenue surprises of -4.76% and 0.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

USANA Health Sciences, Inc. (NYSE: USNA) shares slid in the post-market session after it reported preliminary second-quarter results and updated its FY22 outlook. USANA anticipates Q2 net sales will be ~$265 million (compared to $337 million in 2Q21).

Usana Health Sciences Inc. shares fell in the extended session Wednesday after the nutritional-supplement sales company lowered its forecast for the year, blaming lockdowns in China for disrupting regional sales programs.